Winship Cancer InstituteAtlanta, Georgia, United States
Disclosure information not submitted.
Paper 38 - DEFINING NOVEL BENCHMARK VALUES FOR OUTCOMES OF COMPREHENSIVE RESECTION OF PRIMARY RETROPERITONEAL LIPOSARCOMA
Friday, November 15, 20248:00 AM – 9:00 AM PST
Paper 39 - HISTOLOGIC ORGAN INFILTRATION AND RELATION WITH SURGEON PREOPERATIVE ASSESSMENT IN RETROPERITONEAL SARCOMA. A STUDY FROM TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Paper 42 - HISTOLOGY AND MALIGNANCY GRADE ACCURACY OF PREOPERATIVE BIOPSY OF PRIMARY RETROPERITONEAL SARCOMA. A STUDY FROM THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Paper 77 - A RANDOMIZED PHASE III TRIAL OF DOXORUBICIN + PEMBROLIZUMAB VERSUS DOXORUBICIN ALONE FOR TREATMENT OF UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND RELATED POORLY DIFFERENTIATED SARCOMAS: ECOG-ACRIN EA7222
Saturday, November 16, 20249:00 AM – 10:00 AM PST
